Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.15B |
| 2 |
Tesla
TSLA
|
+$1.26B |
| 3 |
Vanguard FTSE Europe ETF
VGK
|
+$610M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$482M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$461M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$667M |
| 2 |
iShares Floating Rate Bond ETF
FLOT
|
+$652M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$645M |
| 4 |
Meta Platforms (Facebook)
META
|
+$583M |
| 5 |
iShares MSCI United Kingdom ETF
EWU
|
+$507M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.96% |
| 2 | Consumer Discretionary | 3.1% |
| 3 | Financials | 1.5% |
| 4 | Healthcare | 1.15% |
| 5 | Communication Services | 1.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6651
Aspen Aerogels
ASPN
$518M
| $388K | ﹤0.01% |
49,135
+33,957
| +224% | +$236K |
|
|
OWNS
6652
CCM Affordable Housing MBS ETF
OWNS
$105M
| $388K | ﹤0.01% |
22,665
-5,759
| -20% | -$99.6K |
|
6653
PUT
Kosmos Energy
KOS
$1.48B
| $388K | ﹤0.01% |
64,700
+49,700
| +331% | +$324K |
|
6654
National Healthcare
NHC
$3.38B
| $388K | ﹤0.01% |
6,269
-9,325
| -60% | -$553K |
|
6655
CALL
Vera Therapeutics
VERA
$2.36B
| $387K | ﹤0.01% |
+24,100
| New | +$218K |
|
6656
Nurix Therapeutics
NRIX
$2.65B
| $387K | ﹤0.01% |
+38,707
| New | +$395K |
|
6657
WisdomTree International AI Enhanced Value Fund
AIVI
$63.9M
| $386K | ﹤0.01% |
9,909
-116,127
| -92% | -$4.61M |
|
6658
Hope Bancorp
HOPE
$1.79B
| $386K | ﹤0.01% |
45,891
-20,966
| -31% | -$183K |
|
6659
Innovator US Equity Power Buffer ETF September
PSEP
$841M
| $386K | ﹤0.01% |
11,795
-14,765
| -56% | -$462K |
|
6660
CALL
CDW
CDW
$17B
| $385K | ﹤0.01% |
2,100
-19,400
| -90% | -$3.39M |
|
6661
PUT
ArcBest
ARCB
$3.08B
| $385K | ﹤0.01% |
3,900
+1,600
| +70% | +$143K |
|
6662
Anika Therapeutics
ANIK
$287M
| $385K | ﹤0.01% |
+14,821
| New | +$397K |
|
6663
SFL Corp
SFL
$1.61B
| $384K | ﹤0.01% |
41,204
+21,672
| +111% | +$196K |
|
6664
Franklin Genomic Advancements ETF
HELX
$31M
| $384K | ﹤0.01% |
12,714
+3,158
| +33% | +$95.6K |
|
6665
Powell Industries
POWL
$7.71B
| $384K | ﹤0.01% |
19,029
+4,443
| +30% | +$76.9K |
|
6666
CALL
ADMA Biologics
ADMA
$2.22B
| $384K | ﹤0.01% |
104,100
+5,500
| +6% | +$20.4K |
|
6667
PUT
Axalta
AXTA
$8.17B
| $384K | ﹤0.01% |
+11,700
| New | +$363K |
|
6668
Simplify Hedged Equity ETF
HEQT
$303M
| $384K | ﹤0.01% |
+15,464
| New | +$374K |
|
6669
RLJ Lodging Trust
RLJ
$1.69B
| $383K | ﹤0.01% |
37,330
+16,529
| +79% | +$172K |
|
6670
CALL
Blue Owl Capital
OWL
$18.5B
| $383K | ﹤0.01% |
32,900
-5,500
| -14% | -$59.2K |
|
6671
CALL
Atomera
ATOM
$214M
| $383K | ﹤0.01% |
+43,700
| New | +$345K |
|
6672
PUT
Archer Aviation
ACHR
$4.26B
| $383K | ﹤0.01% |
+93,000
| New | +$262K |
|
|
JHAA
6673
DELISTED
Nuveen Corporate Income 2023 Target Term Fund
JHAA
| $383K | ﹤0.01% |
40,956
+21,461
| +110% | +$199K |
|
|
TRHC
6674
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $383K | ﹤0.01% |
46,382
-11,999
| -21% | -$71.8K |
|
6675
Seres Therapeutics
MCRB
$48.9M
| $382K | ﹤0.01% |
3,992
+2,013
| +102% | +$219K |
|
Similar funds
Jane Street's Q2 2023 Portfolio in Review
As of Q2 2023, Jane Street held 10,215 positions worth $297B, up 22% from $244B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Jane Street deployed $26.9B of net new capital in Q2 2023, opening 1,302 new positions and adding to 3,894 existing holdings. Its largest new stake was Kenvue: 10,291,011 shares worth $272M.
By sector, the portfolio is most concentrated in Technology at 4% of assets, up from 2.5% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $667M trimmed.
- Jane Street's largest Q2 2023 buy was Kenvue: 10,291,011 shares worth $272M.
- Jane Street added most to Apple in Q2 2023, an estimated $2.15B increase.
- Jane Street's biggest Q2 2023 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $667M.
- Jane Street fully exited JPMorgan BetaBuilders Europe ETF in Q2 2023, selling an estimated $325M.
- Jane Street's ten largest holdings make up 36% of its $297B portfolio in Q2 2023.
- Jane Street opened 1,302 new positions and closed 1,631 in Q2 2023.
- Jane Street's portfolio value rose 22% quarter-over-quarter to $297B.
Based on Jane Street's 13F filing for Q2 2023, filed 14 Aug 2023.